NHC Reports 2024 Year End Earnings
National HealthCare (NYSE American: NHC) reported strong financial results for 2024, with net operating revenues and grant income reaching $1.31 billion, a 14.5% increase from 2023's $1.14 billion. The growth was driven by a 9.4% increase in same-facility revenues and the strategic acquisition of White Oak Manor on August 1, 2024, which added 22 healthcare operations to NHC's portfolio.
The company's GAAP net income for 2024 rose to $101.9 million ($6.53 per diluted share), up from $66.8 million ($4.34 per diluted share) in 2023. Adjusted net income, excluding unrealized gains in marketable equity securities, increased 39.9% to $76.9 million ($4.93 per diluted share) from $54.9 million ($3.55 per diluted share) in 2023.
National HealthCare (NYSE American: NHC) ha riportato risultati finanziari solidi per il 2024, con ricavi operativi netti e reddito da sovvenzioni che hanno raggiunto 1,31 miliardi di dollari, un incremento del 14,5% rispetto ai 1,14 miliardi di dollari del 2023. La crescita è stata guidata da un incremento del 9,4% nei ricavi delle stesse strutture e dall'acquisizione strategica di White Oak Manor il 1° agosto 2024, che ha aggiunto 22 operazioni sanitarie al portafoglio di NHC.
Il reddito netto GAAP dell'azienda per il 2024 è salito a 101,9 milioni di dollari (6,53 dollari per azione diluita), in aumento rispetto ai 66,8 milioni di dollari (4,34 dollari per azione diluita) del 2023. Il reddito netto rettificato, escludendo i guadagni non realizzati in titoli azionari commerciabili, è aumentato del 39,9% a 76,9 milioni di dollari (4,93 dollari per azione diluita) rispetto ai 54,9 milioni di dollari (3,55 dollari per azione diluita) del 2023.
National HealthCare (NYSE American: NHC) reportó resultados financieros sólidos para 2024, con ingresos operativos netos e ingresos de subvenciones alcanzando 1.31 mil millones de dólares, un aumento del 14.5% en comparación con los 1.14 mil millones de dólares de 2023. El crecimiento fue impulsado por un aumento del 9.4% en los ingresos de las mismas instalaciones y la adquisición estratégica de White Oak Manor el 1 de agosto de 2024, que añadió 22 operaciones de atención médica al portafolio de NHC.
El ingreso neto GAAP de la empresa para 2024 aumentó a 101.9 millones de dólares (6.53 dólares por acción diluida), en comparación con los 66.8 millones de dólares (4.34 dólares por acción diluida) en 2023. El ingreso neto ajustado, excluyendo las ganancias no realizadas en valores de acciones negociables, aumentó un 39.9% a 76.9 millones de dólares (4.93 dólares por acción diluida) desde 54.9 millones de dólares (3.55 dólares por acción diluida) en 2023.
National HealthCare (NYSE American: NHC)는 2024년 강력한 재무 결과를 보고했으며, 순 운영 수익 및 보조금 수익이 13억 1천만 달러에 도달하여 2023년의 11억 4천만 달러에 비해 14.5% 증가했습니다. 이 성장은 동일 시설 수익 9.4% 증가와 2024년 8월 1일 White Oak Manor의 전략적 인수에 의해 주도되었으며, 이는 NHC의 포트폴리오에 22개의 의료 운영을 추가했습니다.
회사의 2024년 GAAP 순이익은 1억 1천9백만 달러 (희석 주당 6.53달러)로 증가했으며, 2023년의 6천6백80만 달러 (희석 주당 4.34달러)에서 증가했습니다. 시장성 있는 주식 증권의 미실현 이익을 제외한 조정 순이익은 39.9% 증가하여 2023년의 5천4백90만 달러 (희석 주당 3.55달러)에서 7천6백90만 달러 (희석 주당 4.93달러)로 증가했습니다.
National HealthCare (NYSE American: NHC) a annoncé des résultats financiers solides pour 2024, avec des revenus d'exploitation nets et des revenus de subventions atteignant 1,31 milliard de dollars, soit une augmentation de 14,5 % par rapport aux 1,14 milliard de dollars de 2023. La croissance a été soutenue par une augmentation de 9,4 % des revenus des mêmes établissements et l'acquisition stratégique de White Oak Manor le 1er août 2024, qui a ajouté 22 opérations de soins de santé au portefeuille de NHC.
Le revenu net GAAP de l'entreprise pour 2024 a augmenté à 101,9 millions de dollars (6,53 dollars par action diluée), contre 66,8 millions de dollars (4,34 dollars par action diluée) en 2023. Le revenu net ajusté, excluant les gains non réalisés sur titres de participation négociables, a augmenté de 39,9 % pour atteindre 76,9 millions de dollars (4,93 dollars par action diluée) contre 54,9 millions de dollars (3,55 dollars par action diluée) en 2023.
National HealthCare (NYSE American: NHC) berichtete für 2024 über starke finanzielle Ergebnisse, mit Nettobetriebseinnahmen und Zuschusseinnahmen von 1,31 Milliarden US-Dollar, was einem Anstieg von 14,5% gegenüber 1,14 Milliarden US-Dollar im Jahr 2023 entspricht. Das Wachstum wurde durch einen 9,4%igen Anstieg der Einnahmen aus denselben Einrichtungen und die strategische Akquisition von White Oak Manor am 1. August 2024, die 22 Gesundheitsbetriebe zum Portfolio von NHC hinzufügte, vorangetrieben.
Das GAAP-Nettoeinkommen des Unternehmens für 2024 stieg auf 101,9 Millionen US-Dollar (6,53 US-Dollar pro verwässerter Aktie), gegenüber 66,8 Millionen US-Dollar (4,34 US-Dollar pro verwässerter Aktie) im Jahr 2023. Das bereinigte Nettoeinkommen, ohne nicht realisierte Gewinne aus handelbaren Eigenkapitalwertpapieren, stieg um 39,9% auf 76,9 Millionen US-Dollar (4,93 US-Dollar pro verwässerter Aktie) von 54,9 Millionen US-Dollar (3,55 US-Dollar pro verwässerter Aktie) im Jahr 2023.
- 14.5% increase in annual revenue to $1.31B
- 39.9% growth in adjusted net income to $76.9M
- 9.4% increase in same-facility revenues
- Strategic expansion through White Oak Manor acquisition (22 facilities)
- 62.7% increase in Q4 adjusted net income
- Q4 2024 GAAP net income declined to $6.1M from $28.4M in Q4 2023
Insights
National HealthCare 's 2024 financial results demonstrate exceptional growth across multiple dimensions, with revenues reaching
The
The August 2024 White Oak Manor acquisition represents a transformative expansion, adding 22 facilities to NHC's portfolio. Based on the fourth quarter results, this acquisition appears to be integrating successfully, contributing to the remarkable
The substantial gap between GAAP and adjusted earnings warrants attention. While adjusted earnings grew impressively, GAAP quarterly earnings actually declined from
These results position NHC favorably in the growing senior healthcare market, with demonstrated ability to drive both organic growth and successfully integrate acquisitions. The company's expanded footprint should provide economies of scale and enhanced geographic coverage, potentially supporting continued margin expansion in 2025.
For the year ended December 31, 2024, the reported GAAP net income attributable to NHC was
For the quarter ended December 31, 2024, the reported GAAP net income attributable to NHC was
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About NHC
NHC affiliates operate for themselves and third parties 80 skilled nursing facilities with 10,341 beds. NHC affiliates also operate 26 assisted living communities with 1,413 units, nine independent living communities with 777 units, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.
Consolidated Statements of Operations | |||||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||||
Three Months Ended | Years Ended | ||||||||||||||
December 31 | December 31 | ||||||||||||||
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
||||
Revenues and grant income: | |||||||||||||||
Net patient revenues | $ |
357,344 |
|
$ |
282,997 |
|
$ |
1,251,759 |
|
$ |
1,087,614 |
|
|||
Other revenues |
|
12,006 |
|
|
17,917 |
|
|
46,178 |
|
|
53,930 |
|
|||
Government stimulus income |
|
- |
|
|
- |
|
|
9,445 |
|
|
- |
|
|||
Net operating revenues and grant income |
|
369,350 |
|
|
300,914 |
|
|
1,307,382 |
|
|
1,141,544 |
|
|||
Costs and expenses: | |||||||||||||||
Salaries, wages and benefits |
|
234,321 |
|
|
186,562 |
|
|
810,930 |
|
|
712,344 |
|
|||
Other operating |
|
83,298 |
|
|
70,970 |
|
|
321,390 |
|
|
288,183 |
|
|||
Facility rent |
|
11,378 |
|
|
11,438 |
|
|
43,182 |
|
|
41,525 |
|
|||
Depreciation and amortization |
|
11,442 |
|
|
11,768 |
|
|
41,985 |
|
|
42,034 |
|
|||
Interest |
|
2,347 |
|
|
56 |
|
|
4,135 |
|
|
324 |
|
|||
Total costs and expenses |
|
342,786 |
|
|
280,794 |
|
|
1,221,622 |
|
|
1,084,410 |
|
|||
Income from operations |
|
26,564 |
|
|
20,120 |
|
|
85,760 |
|
|
57,134 |
|
|||
Non-operating income |
|
4,825 |
|
|
4,544 |
|
|
19,690 |
|
|
16,660 |
|
|||
Unrealized gains/(losses) on marketable equity securities |
|
(25,332 |
) |
|
12,001 |
|
|
30,958 |
|
|
14,944 |
|
|||
Income before income taxes |
|
6,057 |
|
|
36,665 |
|
|
136,408 |
|
|
88,738 |
|
|||
Income tax provision |
|
(28 |
) |
|
(8,700 |
) |
|
(34,322 |
) |
|
(23,450 |
) |
|||
Net income |
|
6,029 |
|
|
27,965 |
|
|
102,086 |
|
|
65,288 |
|
|||
Net (income)/loss attributable to noncontrolling interest |
|
52 |
|
|
441 |
|
|
(159 |
) |
|
1,510 |
|
|||
Net income attributable to National HealthCare Corporation | $ |
6,081 |
|
$ |
28,406 |
|
$ |
101,927 |
|
$ |
66,798 |
|
|||
Net income per common share | |||||||||||||||
Basic | $ |
0.39 |
|
$ |
1.86 |
|
$ |
6.62 |
|
$ |
4.36 |
|
|||
Diluted | $ |
0.39 |
|
$ |
1.83 |
|
$ |
6.53 |
|
$ |
4.34 |
|
|||
Weighted average common shares outstanding | |||||||||||||||
Basic |
|
15,420,658 |
|
|
15,306,253 |
|
|
15,393,782 |
|
|
15,310,142 |
|
|||
Diluted |
|
15,665,025 |
|
|
15,486,573 |
|
|
15,598,528 |
|
|
15,377,343 |
|
|||
Dividends declared per common share | $ |
0.61 |
|
$ |
0.59 |
|
$ |
2.42 |
|
$ |
2.34 |
|
|||
Balance Sheet Data | December 31 | December 31 | |||||||||||||
(in thousands) |
|
2024 |
|
|
2023 |
|
|||||||||
Cash, cash equivalents and marketable securities | $ |
216,185 |
|
$ |
223,620 |
|
|||||||||
Restricted cash, cash equivalents and marketable securities |
|
163,795 |
|
|
167,971 |
|
|||||||||
Current assets |
|
424,408 |
|
|
406,235 |
|
|||||||||
Property and equipment, net |
|
684,289 |
|
|
493,329 |
|
|||||||||
Total assets |
|
1,524,429 |
|
|
1,310,796 |
|
|||||||||
Current liabilities, excluding long-term debt due within one year |
|
227,297 |
|
|
214,476 |
|
|||||||||
Current and long-term debt |
|
137,000 |
|
|
- |
|
|||||||||
NHC stockholders' equity |
|
980,161 |
|
|
908,752 |
|
Selected Operating Statistics | ||||||||||||||||
Three Months Ended | Years Ended | |||||||||||||||
December 31 | December 31 | |||||||||||||||
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|||||
Skilled Nursing Per Diems: | ||||||||||||||||
Medicare | $ |
607.67 |
|
$ |
579.84 |
|
$ |
586.76 |
|
$ |
559.07 |
|
||||
Managed Care |
|
490.41 |
|
|
478.51 |
|
|
468.23 |
|
|
464.89 |
|
||||
Medicaid |
|
279.02 |
|
|
268.58 |
|
|
275.78 |
|
|
253.95 |
|
||||
Private Pay and Other |
|
321.12 |
|
|
290.85 |
|
|
316.80 |
|
|
282.14 |
|
||||
Average Skilled Nursing Per Diem | $ |
350.72 |
|
$ |
337.57 |
|
(1) |
$ |
346.46 |
|
(1) |
$ |
324.53 |
|
(1) |
|
Skilled Nursing Patient Days: | ||||||||||||||||
Medicare |
|
84,809 |
|
|
79,025 |
|
|
320,524 |
|
|
318,253 |
|
||||
Managed Care |
|
76,996 |
|
|
62,031 |
|
|
276,019 |
|
|
242,023 |
|
||||
Medicaid |
|
374,755 |
|
|
288,538 |
|
|
1,281,020 |
|
|
1,140,612 |
|
||||
Private Pay and Other |
|
191,926 |
|
|
170,916 |
|
|
677,449 |
|
|
663,195 |
|
||||
Total Skilled Nursing Patient Days |
|
728,486 |
|
|
600,510 |
|
(1) |
|
2,555,012 |
|
(1) |
|
2,364,083 |
|
(1) |
|
(1) NHC exited three skilled nursing facilities in |
||||||||||||||||
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | ||||||||||||||||
Three Months Ended | Years Ended | |||||||||||||||
December 31 | December 31 | |||||||||||||||
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|||||
Net income attributable to National Healthcare Corporation | $ |
6,081 |
|
$ |
28,406 |
|
$ |
101,927 |
|
$ |
66,798 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
25,332 |
|
|
(12,001 |
) |
|
(30,958 |
) |
|
(14,944 |
) |
||||
Gain on sale of property and equipment |
|
- |
|
|
(6,230 |
) |
|
- |
|
|
(6,230 |
) |
||||
Gain on sale of unconsolidated company |
|
- |
|
|
- |
|
|
(1,024 |
) |
|
- |
|
||||
Operating results for newly opened operations not at full capacity (2) |
|
(10 |
) |
|
742 |
|
|
130 |
|
|
2,359 |
|
||||
Stock-based compensation expense |
|
1,098 |
|
|
663 |
|
|
4,160 |
|
|
2,782 |
|
||||
Acquisition-related expenses (3) |
|
435 |
|
|
- |
|
|
3,266 |
|
|
- |
|
||||
Employee retention credit |
|
- |
|
|
- |
|
|
(9,445 |
) |
|
- |
|
||||
Income tax provision on non-GAAP adjustments |
|
(6,982 |
) |
|
4,375 |
|
|
8,806 |
|
|
4,169 |
|
||||
Non-GAAP Net income | $ |
25,954 |
|
$ |
15,955 |
|
$ |
76,862 |
|
$ |
54,934 |
|
||||
GAAP diluted earnings per share | $ |
0.39 |
|
$ |
1.83 |
|
$ |
6.53 |
|
$ |
4.34 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
1.20 |
|
|
(0.57 |
) |
|
(1.47 |
) |
|
(0.72 |
) |
||||
Gain on sale of property and equipment |
|
- |
|
|
(0.30 |
) |
|
- |
|
|
(0.30 |
) |
||||
Gain on sale of unconsolidated company |
|
- |
|
|
- |
|
|
(0.05 |
) |
|
- |
|
||||
Operating results for newly opened operations not at full capacity (2) |
|
- |
|
|
0.04 |
|
|
0.01 |
|
|
0.10 |
|
||||
Stock-based compensation expense |
|
0.05 |
|
|
0.03 |
|
|
0.20 |
|
|
0.13 |
|
||||
Acquisition-related expenses (3) |
|
0.02 |
|
|
- |
|
|
0.16 |
|
|
- |
|
||||
Employee retention credit |
|
- |
|
|
- |
|
|
(0.45 |
) |
|
- |
|
||||
Non-GAAP diluted earnings per share | $ |
1.66 |
|
$ |
1.03 |
|
$ |
4.93 |
|
$ |
3.55 |
|
||||
(2) The operating results for newly opened facilities or agencies not at full capacity include healthcare operations that are still considered in the start-up phase, which are two hospice agencies for the fourth quarter and year ended December 31, 3024. For the fourth quarter and year ended December 31, 2023, included are two behavioral health hospitals, two homecare agencies, and two hospice agencies. | ||||||||||||||||
(3) Represents expenses incurred to acquire the White Oak operations that are not capitalizable. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250227122228/en/
Brian F. Kidd, SVP/CFO
Phone: (615) 890-2020
Source: National HealthCare Corporation
FAQ
What was NHC's revenue growth in 2024 compared to 2023?
How many facilities did NHC acquire through the White Oak Manor acquisition in 2024?
What was NHC's adjusted earnings per share for full-year 2024?
How much did NHC's same-facility revenues increase in 2024?